Ledger.Open graph →
SEC Form D · filed February 12, 2021

Outlook Therapeutics, Inc

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MONMOUTH JUNCTION, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Gerd G. Auffarth · Monmouth Junction, NJDirectorYezan Haddadin · Monmouth Junction, NJDirectorRandy Thurman · Monmouth Junction, NJDirectorLawrence A. Kenyon · Monmouth Junction, NJExec · DirectorFaisal G. Sukhtian · Monmouth Junction, NJDirectorJulian G. Gangolli · Monmouth Junction, NJDirectorKurt J. Hilzinger · Monmouth Junction, NJDirectorAndong G. Huang · Monmouth Junction, NJDirectorGary M. Inman · Fargo, NDDirectorChristi M. Offutt · Fargo, NDDirectorEric S. Espinosa, M.D · Columbus, OHDirectorBlake J. Nelson · Fargo, NDExec · DirectorMichael S. Cunningham, M.D · Columbus, OHDirectorGhentry Pace · Columbus, OHDirectorJon K. Aarsvold · Fargo, NDDirectorCharles R. Kenley · WEST LAFAYETTE, INDirectorJoe F. Teague, Jr · Charlottes, NCDirectorWai S. Wong · Singapore, U0DirectorWilliam L. Lancaster · Calgary, British Columbia, CanadaExec · DirectorWendy B. Modlin · New York, NYDirectorAryeh B. Bourkoff · New York, NYDirectorEhren B. Stenzler · New York, NYDirectorAndong G. Huang · Monmouth Junction, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗